In May AGSD-UK facilitated a meeting of UK metabolic specialists to discuss guidelines for management of hepatic GSDs.
The Spring 2019 edition of our magazine Glisten is out now, 60 pages packed with news and information.
The U.S. FDA has granted Breakthrough Therapy Designation to Amicus’ AT-GAA in Late Onset Pompe Disease.
Dr David Weinstein reports rewarding preliminary results from the first ever gene therapy trial in a Glycogen Storage Disease.
A case report from the national McArdle Clinic highlights the benefits achieved through strength training with a local personal trainer.